Press Releases

Data Further Supports the Potential of the Company’s Therapeutic Platform to Improve Immunotherapy Outcomes for Patients with Liver and Pancreatic Tumors DENVER and CHICAGO, February 16, 2023  – TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”), an oncology company in the process of going
February 16, 2023

Subscribe to Email Alerts

Get news delivered directly to your in box